Prevalence of Microalbuminuria in Non-diabetic Hypertensive Patients and its Correlation with Changes in Left

Khema Raj Bhusal1, Surya Devkota2, Surya Pathak3

  • 1Tribhuwan University Teaching Hospital.

Abstract

Insights

Microalbuminuria, an early sign of kidney damage, was prevalent in non-diabetic hypertensive patients. However, this study found no significant correlation between microalbuminuria and cardiovascular changes in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Background:

  • Microalbuminuria (30-300 mg/24 hours) indicates abnormal albumin excretion and epithelial dysfunction.
  • It is a risk factor for target organ damage, including stroke, retinopathy, and cardiovascular events.
  • Early detection is crucial for managing associated risks.

Purpose of the Study:

  • To determine the prevalence of microalbuminuria in non-diabetic hypertensive patients.
  • To investigate the correlation between microalbuminuria and cardiovascular changes in this cohort.

Main Methods:

  • A quantitative cross-sectional study involving 107 non-diabetic hypertensive patients.
  • Assessed parameters included basic metabolic profile, urine evaluation, and echocardiography.
  • Participants were recruited from Manmohan Memorial Medical College and Teaching Hospital.

Main Results:

  • Microalbuminuria was detected in 28 participants (26.2%) and absent in 79 (73.8%).
  • No significant differences in microalbuminuria prevalence were observed concerning left ventricular hypertrophy, diastolic dysfunction, left atrial size, or ejection fraction.
  • Specific p-values indicated no statistical significance for these correlations.

Conclusions:

  • The study found no significant association between microalbuminuria and cardiovascular changes in non-diabetic hypertensive patients.
  • Further research may be needed to explore other potential contributing factors or markers in this population.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
27
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
16
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K